Skip to contentE
Editas Medicine, Inc.
E
EDITEditas Medicine, Inc. Q1 2018 · 10-Q
Revenue$3.93M$3.93M+475.8% vs Q1 2017 Net Income-$30.94M-$30.94MN/M vs Q1 2017 EPS Diluted-$0.67-$0.67N/M vs Q1 2017 Operating Income-$31,559,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Editas Medicine, Inc. · CIK 1650664 · Engraved from SEC EDGAR
Free Cash Flowderived-$23,471,000N/M Margins · derivedOperating margin-803.6%+3687.1 pt vs Q1 2017
Net margin-787.9%+3771.8 pt vs Q1 2017
ended Mar 31, 2018 · filed May 4, 2018 · 34 d after period end